Merck KGaA
MKKGY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $5,318 | $5,255 | $5,280 | $5,418 |
| % Growth | 1.2% | -0.5% | -2.5% | – |
| Cost of Goods Sold | $2,105 | $2,228 | $2,135 | $2,319 |
| Gross Profit | $3,213 | $3,027 | $3,145 | $3,099 |
| % Margin | 60.4% | 57.6% | 59.6% | 57.2% |
| R&D Expenses | $660 | $539 | $551 | $527 |
| G&A Expenses | $332 | $354 | $355 | $415 |
| SG&A Expenses | $1,460 | $1,476 | $1,467 | $1,049 |
| Sales & Mktg Exp. | $1,128 | $1,122 | $1,112 | $634 |
| Other Operating Expenses | -$128 | $121 | $121 | $699 |
| Operating Expenses | $1,992 | $2,136 | $2,139 | $2,275 |
| Operating Income | $1,221 | $891 | $1,006 | $824 |
| % Margin | 23% | 17% | 19.1% | 15.2% |
| Other Income/Exp. Net | -$99 | -$62 | -$50 | -$16 |
| Pre-Tax Income | $1,122 | $829 | $956 | $808 |
| Tax Expense | $225 | $174 | $218 | $140 |
| Net Income | $902 | $652 | $735 | $667 |
| % Margin | 17% | 12.4% | 13.9% | 12.3% |
| EPS | 0.41 | 0.3 | 0.34 | 0.31 |
| % Growth | 36.7% | -11.8% | 9.7% | – |
| EPS Diluted | 0.41 | 0.3 | 0.34 | 0.31 |
| Weighted Avg Shares Out | 2,179 | 2,174 | 2,175 | 2,175 |
| Weighted Avg Shares Out Dil | 2,179 | 2,174 | 2,175 | 2,175 |
| Supplemental Information | – | – | – | – |
| Interest Income | $27 | $17 | $28 | $22 |
| Interest Expense | $126 | $79 | $78 | $59 |
| Depreciation & Amortization | $458 | $457 | $473 | $551 |
| EBITDA | $1,706 | $1,365 | $1,507 | $1,419 |
| % Margin | 32.1% | 26% | 28.5% | 26.2% |